Safety and efficacy study in achieving ad lib consumption of peanut with Viaskin® peanut patch in peanut allergic infants 6 through 12 months of age
Peanut allergy is common and usually lasts for life. This clinical trial investigates whether a special skin patch called Viaskin® can help treat peanut allergy in babies aged between 6 and 12 months. The patch delivers a tiny speck of peanut protein through the skin each day. This is designed to slowly train the child's immune system to become less sensitive to peanuts, lowering the danger of severe allergic reactions. Babies in the study will wear one patch every day for three years while strictly avoiding peanuts in their food. At the end of three years, doctors will give the children a closely watched peanut test to see if their bodies can now tolerate peanuts. Depending on the results, families will be guided on whether they can safely start introducing peanut-containing foods into their child's normal diet.
At a glance
What is this study about?
Peanut allergy is one of the most common food allergies in the UK and worldwide. For most children, it does not go away as they grow older. Even tiny accidental bites of peanut can cause scary, sudden allergic reactions. Right now, the standard advice is simply to avoid peanuts completely and carry emergency medicine, which can cause a lot of worry for families.
This trial is looking at a new treatment called the Viaskin® peanut patch. It works by epicutaneous immunotherapy, which simply means training the immune system through the skin. Each patch contains a microscopic amount of peanut protein—about one thousandth of a single peanut. Over time, this gentle exposure aims to desensitise the child's body so that accidental contact is far less dangerous.
While this patch has already been tested in toddlers and older children, researchers want to see if starting treatment much earlier—between 6 and 12 months of age—works even better. The main goal is to find out whether three years of wearing the patch allows children to safely eat peanut foods freely as they grow up.
Key takeaways
- The trial tests a daily peanut skin patch for babies aged 6 to 12 months.
- The aim is to help babies become less sensitive to peanuts over time.
- The main patch treatment lasts for three years, followed by a one-year follow-up.
- All feeding tests are supervised in a safe hospital or clinic setting.
- Participation is entirely voluntary and you can withdraw at any point.
Who may be eligible?
This trial is open to babies aged between 6 and 12 months who have a confirmed peanut allergy and weigh at least 7 kg (around 15.4 lbs). The baby must currently be on a strict diet that completely avoids peanuts.
Babies cannot take part if they have had life-threatening allergic reactions in the past, such as severe drops in blood pressure, loss of consciousness, or needing intensive care. They also cannot take part if they have severe skin problems on their back where the patch needs to go, or if they have an allergy to medical adhesives.
Additionally, babies who have needed multiple courses of steroid medicines for chest wheezing, or those who have had previous allergy desensitisation treatments or certain biologic medicines, will not be able to join. The study doctors will do careful checks to ensure taking part is as safe as possible for your baby.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- My baby is between 6 and 12 months old.
- My baby weighs at least 7 kg (15.4 lbs).
- A doctor has diagnosed my baby with a peanut allergy.
- My baby has not had a life-threatening reaction requiring intensive care.
- My baby does not have severe skin rashes or eczema on their back.
- We are currently keeping our baby on a strict peanut-free diet.
What does participation involve?
Taking part begins with screening tests to confirm your baby's allergy. These checks may include simple skin prick tests, blood samples, and a food challenge. During a food challenge, your baby is given tiny, increasing amounts of peanut in a hospital clinic while doctors and nurses watch closely to manage any symptoms immediately.
If your baby joins the study, you will apply one new patch to their back every day for three years. During this time, your child must continue to avoid all peanuts in their food. You will have regular clinic visits so doctors can check your baby's health and skin.
After three years, your child will complete another monitored food challenge in the clinic. Depending on how they respond, doctors will tell you whether your child can start eating peanuts at home during the fourth year, continue using the patch, or keep avoiding peanuts. Caregivers will keep a diary of any foods eaten and track any symptoms during this follow-up year.
Potential risks and benefits
Locations (7)
- Allergy Centre of ExcellenceCity onlyLondon, England
- St. Thomas’ Hospital, Guy’s and St. Thomas’ NHS Foundation TrustCity onlyLondon, England
- Halton Pediatric AllergyCity onlyBurlington, Canada
- SickKids, the Hospital for Sick ChildrenCity onlyToronto, Canada
- Centre Hospitalier Universitaire Sainte-JustineApproximateMontréal, Canada
- Perth Children's HospitalUnverifiedNedlands, Australia
- Royal Children's Hospital MelbourneUnverifiedParkville, Australia
Common questions
Does the patch hurt to wear?
No, the patch does not use needles. It sticks to the skin like a plaster, though it might cause mild redness or itching underneath.
Can my baby eat peanuts while wearing the patch?
No. For the first three years, your baby must strictly avoid eating any foods containing peanuts.
What happens if my baby has an allergic reaction during a clinic test?
Tests take place in a fully equipped clinic with trained medical staff ready to treat any reaction quickly and safely.
Can we bathe our baby while they are wearing the patch?
The study team will give you clear daily instructions on how to apply, remove, and manage the patches around bath time.
Can I leave the study early if I change my mind?
Yes. Taking part is completely voluntary and you can stop at any time without giving a reason or losing standard medical care.
How to find out more
DBV Technologies
Always speak to your GP or specialist before deciding to take part in a study.
Interested in taking part?
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.